Glycobreez F Dpi Capsule
Marketer
Mankind Pharma Ltd
Salt Composition
Formoterol (12mcg) + Glycopyrrolate (25mcg)
Overview Glycobreez F Dpi Capsule
Glycobreez F DPI capsules combine two medications to alleviate breathing difficulties in individuals with chronic obstructive pulmonary disease (COPD). Its mechanism involves suppressing inflammatory chemical messengers, resulting in airway muscle relaxation. Your physician will determine the appropriate inhalation frequency. Maintaining the lowest effective dose for asthma control is crucial. While benefits may appear within days, peak efficacy takes several weeks. Consistent use, even during symptom-free periods, is essential for ongoing effectiveness; cessation may worsen asthma. This medication is not for immediate asthma attack relief; use your rescue inhaler for acute episodes. Common side effects include dyspepsia, rhinopharyngitis, chest discomfort, pyrexia, pharyngitis, cough, cephalgia, sinusitis, nasal inflammation, and urinary tract infections. These should be reported to your doctor, but do not necessitate treatment discontinuation. Rinsing your mouth and throat or brushing your teeth after inhalation may mitigate these effects. Avoid asthma triggers and smoking. Prior to initiating Glycobreez F DPI capsules, inform your doctor about any oral or pulmonary infections, hepatic or renal impairment, and pregnancy or breastfeeding status.
Uses of Glycobreez F Dpi Capsule
Persistent lung disease causing airflow obstruction
Major Benefits of Glycobreez F Dpi Capsule:
Follow your physician's instructions or consult the product label for usage guidelines.
Common Side effects of Glycobreez F Dpi Capsule:
- Indigestion
- High blood pressure
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Chest pain
- Fever
- Urinary retention
- Sore throat
- Cough
- Headache
- Dizziness
- Increased glucose level in blood
- Allergic reaction
- Sinus inflammation
- Inflammation of the nose
- Urinary tract infection
How to use Glycobreez F Dpi Capsule:
Follow your doctor's instructions or consult the product label for usage guidelines.
How Glycobreez F Dpi Capsule works:
Formoterol and glycopyrrolate, combined in Glycobreez F DPI capsules, provide treatment for chronic obstructive pulmonary disease (COPD).
SAFETY ADVICE
AlcoholUNSAFE
Combining Glycobreez F Dpi Capsule and alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glycobreez F DPI capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Glycobreez F Dpi Capsule appears safe for breastfeeding mothers. Available evidence indicates minimal risk to the infant. However, prolonged use of Glycobreez F Dpi Capsule may decrease milk supply.
DrivingNone
No known drug interactions.
KidneyNone
No known drug interactions.
LiverNone
No known drug interactions.
What if you forget to take Glycobreez F Dpi Capsule :
Should you forget to take a Glycobreez F Dpi Capsule, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Glycobreez F Dpi Capsule
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |


